PFE
45
16
HST
37
-2
CHD
42
2
VMC
60
-5
AMP
61
-2
CSCO
67
-5
ADBE
56
-2
AES
37
4
MCHP
43
-12
NRG
82
2
VLO
43
-2
L
51
2
RRC
65
-4
CMA
52
-3
TJX
51
7
CRM
42
-5
EQT
51
-2
URBN
84
9
DVN
27
2
CI
45
5
PFE
45
16
HST
37
-2
CHD
42
2
VMC
60
-5
AMP
61
-2
CSCO
67
-5
ADBE
56
-2
AES
37
4
MCHP
43
-12
NRG
82
2
VLO
43
-2
L
51
2
RRC
65
-4
CMA
52
-3
TJX
51
7
CRM
42
-5
EQT
51
-2
URBN
84
9
DVN
27
2
CI
45
5
Financhill
Back

ARK Innovation ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
84

ARKK
ARK Innovation ETF

Last Price:
$58.04
Seasonality Move:
9.63%
Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
$16.90
Seasonality Move:
2.29%
Buy
84
ARK Innovation ETF (ARKK) is a Buy

Is ARK Innovation ETF a Buy, Sell or Hold?

  • The current ARK Innovation ETF [ARKK] share price is $56.07. The Score for ARKK is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
  • ARKK is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.44. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARKK Stock Price Chart

What is ARK Innovation ETF's stock price today?

  • The ARK Innovation ETF share price today is $56.07
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARKK is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight buying pressure.

ARKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.06 Buy
Relative Strength Index (14 RSI): 59.21 Buy
Chaikin Money Flow: 4626230 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.8 - 56.42) Buy
Bollinger Bands (100): (48.34 - 61.02) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.67 Sell
Relative Strength Index (14 RSI): 42.89 Sell
Chaikin Money Flow: 20534 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.01 - 18.99) Sell
Bollinger Bands (100): (19.23 - 29.65) Sell

ARKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.96 Sell
20-day SMA: 53.79 Buy
50-day SMA: 50.17 Buy
200-day SMA: 52.1 Buy
8-day EMA: 56.11 Sell
20-day EMA: 54.09 Buy
50-day EMA: 52.58 Buy
200-day EMA: 52.02 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.42 Buy
20-day SMA: 18.11 Sell
50-day SMA: 19.97 Sell
200-day SMA: 28.53 Sell
8-day EMA: 17.62 Sell
20-day EMA: 18.04 Sell
50-day EMA: 20.09 Sell
200-day EMA: 28.66 Sell

ARK Innovation ETF Earnings Growth & ARKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.

ARK Innovation ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):